The acellular pertussis vaccine trials: an interpretation.
Plotkin
S A
SA
Pasteur Mérieux Connaught, Marnes-la-Coquette, France.
Cadoz
M
M
D015331:Cohort Studies; D004311:Double-Blind Method; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D005602:France; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D008297:Male; D015337:Multicenter Studies as Topic; D010567:Pertussis Vaccine / Q000008:administration & dosage* / Q000009:adverse effects / Q000145:classification / Q000276:immunology; D016032:Randomized Controlled Trials as Topic; D015164:Vaccines, Inactivated / Q000008:administration & dosage* / Q000009:adverse effects; D014917:Whooping Cough / Q000276:immunology* / Q000517:prevention & control*
D010567:Pertussis Vaccine; D015164:Vaccines, Inactivated